NEW YORK (360Dx) – Beckman Coulter said today that it has received Medical Device License approval from Health Canada for its DxH 900 Hematology Analyzer and its Early Sepsis Indicator.

The two tools were designed to improve a laboratory or institution's ability to detect "critical, potentially life-threatening, blood conditions, and/or diseases like sepsis," Beckman Coulter, which is part of Danaher, said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.